Follow the אורמד share price and the full insider trade history of the company, a listed issuer based in Israel. Shares are quoted on the IL market, under the authority of TASE (ISA). The latest transaction was disclosed on 20 August 2026 (Holding). Among the most active insiders: אקוומרין (ז). All data is free.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
189,484 shares100.0% of flowShareXTAETASE:1691:12729:1141324:2026-03-26
10 of 10 declarations
About אורמד
Oramed is a company focused on developing innovative treatments for diabetes, including oral solutions for insulin administration. It is listed on the XTAE.